These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 12619191)
1. Is visual loss due to giant cell arteritis reversible? Calgüneri M; Cobankara V; Ozatli D; Güler G; Apraş S; Pay S; Kiraz S; Ertenli I; Oztürk MA Yonsei Med J; 2003 Feb; 44(1):155-8. PubMed ID: 12619191 [TBL] [Abstract][Full Text] [Related]
2. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Hayreh SS; Zimmerman B Ophthalmology; 2003 Jun; 110(6):1204-15. PubMed ID: 12799248 [TBL] [Abstract][Full Text] [Related]
3. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Danesh-Meyer H; Savino PJ; Gamble GG Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780 [TBL] [Abstract][Full Text] [Related]
4. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Hayreh SS; Zimmerman B Ophthalmologica; 2003; 217(4):239-59. PubMed ID: 12792130 [TBL] [Abstract][Full Text] [Related]
5. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481 [TBL] [Abstract][Full Text] [Related]
7. An unusual cause of visual loss in a patient with giant cell arteritis. Shakir R; Steuer A Int J Rheum Dis; 2013 Jun; 16(3):359-60. PubMed ID: 23981761 [No Abstract] [Full Text] [Related]
8. Gradual loss and recovery of vision in temporal arteritis. Lipton RB; Solomon S; Wertenbaker C Arch Intern Med; 1985 Dec; 145(12):2252-3. PubMed ID: 4074041 [TBL] [Abstract][Full Text] [Related]
9. Steroid management in giant cell arteritis. Chan CC; Paine M; O'Day J Br J Ophthalmol; 2001 Sep; 85(9):1061-4. PubMed ID: 11520757 [TBL] [Abstract][Full Text] [Related]
13. Recovery of vision in a 47-year-old man with fulminant giant cell arteritis. Postel EA; Pollock SC J Clin Neuroophthalmol; 1993 Dec; 13(4):262-70. PubMed ID: 8113439 [TBL] [Abstract][Full Text] [Related]
14. Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder. Cheema MR; Ismaeel SM Clin Interv Aging; 2016; 11():185-8. PubMed ID: 26966355 [TBL] [Abstract][Full Text] [Related]
15. Role of oral cyclophosphamide in the treatment of giant cell arteritis. Quartuccio L; Maset M; De Maglio G; Pontarini E; Fabris M; Mansutti E; Mariuzzi L; Pizzolitto S; Beltrami CA; De Vita S Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726 [TBL] [Abstract][Full Text] [Related]
16. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case. Ciccarelli M; Jeanmonod D; Jeanmonod R Am J Emerg Med; 2009 Feb; 27(2):255.e1-3. PubMed ID: 19371556 [TBL] [Abstract][Full Text] [Related]
17. Polymyalgia rheumatica and temporal arthritis. Epperly TD; Moore KE; Harrover JD Am Fam Physician; 2000 Aug; 62(4):789-96, 801. PubMed ID: 10969858 [TBL] [Abstract][Full Text] [Related]
18. Steroid refractory giant cell arteritis with bilateral vertebral artery occlusion and middle cerebellar peduncle infarction. Healy S; Simpson M; Kitchen WJ; Jacob A; Crooks D; Rathi N; Biswas S; Fletcher N; Huda S; Sekhar A J R Coll Physicians Edinb; 2019 Jun; 49(2):118-121. PubMed ID: 31188339 [TBL] [Abstract][Full Text] [Related]
19. [The bane of giant cell arteritis from an ophthalmological viewpoint]. Meli B; Landau K; Gloor BP Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521 [TBL] [Abstract][Full Text] [Related]
20. Temporal arteritis: a review and case history. Moltyaner Y; Tenenbaum J J Fam Pract; 1996 Sep; 43(3):294-300. PubMed ID: 8797758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]